| Product Name | MF | CAS | Details |
|---|
| DS-6930 | C23H21N3O4 | 1242328-82-0 | Details |
| Aspochalasin M | C24H35NO4 | 1173040-34-0 | Details |
| BMT-090605 hydrochloride | C21H25ClN4O2 | 2231664-45-0 | Details |
| Sipagladenant | C20H19N3O4S | 858979-50-7 | Details |
| Claficapavir | C17H12ClNO4S2 | 2055732-24-4 | Details |
| Anticancer agent 43 | C14H9FN2O3S2 | 2470015-35-9 | Details |
| ERCC1-XPF-IN-2 | C15H13Cl2NO3 | 1808986-37-9 | Details |
| BTK-IN-16 | C15H14N4O2 | 2883232-92-4 | Details |
| Antibacterial agent 26 | C19H17N5O2 | 75369-40-3 | Details |
| Chitin synthase inhibitor 2 | C20H19N3O3 | 2416338-24-2 | Details |
| DDX3-IN-2 | C20H23N5O | 1919828-81-1 | Details |
| (R)-BDP9066 | C20H24N6 | 2284549-25-1 | Details |
| SLF1081851 | C21H33N3O | 2763730-97-6 | Details |
| MRK-623 | C20H17FN4O | 461449-78-5 | Details |
| α-Glucosidase-IN-2 | C17H11N3O2S2 | 2699784-18-2 | Details |
| MDH1-IN-1 | C21H25NO4 | 2143463-31-2 | Details |
| BCR-ABL1-IN-1 | C18H12F3N3O2 | 1488090-21-6 | Details |
| Bromodomain inhibitor-10 | C20H20N4O3 | 1870849-58-3 | Details |
| BRD-8899 | C17H22N4O3S | 1404437-50-8 | Details |
| Pixantrone hydrochloride | C17H20ClN5O2 | 175989-38-5 | Details |
| Tubulin inhibitor 27 | C21H19NO4 | 184579-57-5 | Details |
| Tubulin inhibitor 18 | C22H26O5 | 2762382-51-2 | Details |
| DSS30 | C16H14ClNO3S2 | 883027-32-5 | Details |
| IM-93 | C21H28N4O2 | 1173657-73-2 | Details |
| Sulfinalol | C20H27NO4S | 66264-77-5 | Details |
| GRK6-IN-2 | C21H21FN6 | 2677786-27-3 | Details |
| Neldazosin | C18H25N5O4 | 109713-79-3 | Details |
| OTS964 | C23H24N2O2S | 1338542-14-5 | Details |
| CB1/2 agonist 3 | C25H41NO2 | 2772655-86-2 | Details |
| S 17092 | C22H28N2O2S | 176797-26-5 | Details |
| AGN 192870 | C27H22O2 | 166977-57-7 | Details |
| XT2 | C19H14FN5OS | 2582816-37-1 | Details |
| BRD3731 | C24H31N3O | 2056262-07-6 | Details |
| CC214-2 | C20H25N5O3 | 1228012-18-7 | Details |
| p38-α MAPK-IN-4 | C17H13BrN2O | 2396754-57-5 | Details |
| SARS-CoV-2-IN-13 | C13H8Cl2N2O4 | 56961-10-5 | Details |
| Atg4B-IN-2 | C21H30O3 | 2765008-88-4 | Details |
| UCPH-102 | C21H18N2O2 | 1229591-56-3 | Details |
| Myt1-IN-1 | C16H15ClN4O2 | 2719749-02-5 | Details |
| Izuforant | C12H12BrN7 | 1429374-83-3 | Details |
| IAB15 | C15H14F3NO2 | 2987139-91-1 | Details |
| Diamthazole | C15H23N3OS | 95-27-2 | Details |
| CXCR2 antagonist 8 | C14H13N3O5 | 182498-30-2 | Details |
| MIF-IN-2 | C14H10ClN3O4 | 2756410-57-6 | Details |
| Butofilolol | C17H26FNO3 | 58930-32-8 | Details |
| EM127 | C14H18ClN3O3 | 1886879-71-5 | Details |
| Metallo-β-lactamase-IN-8 | C13H11ClN2O4S | 1610537-25-1 | Details |
| SK1- I hydrochloride | C17H28ClNO2 | 2366222-05-9 | Details |
| α-Glucosidase-IN-4 | C19H14O4 | 2410538-67-7 | Details |
| Cannabicitran | C21H30O2 | 31508-71-1 | Details |
| Antibacterial agent 105 | C14H9N3O5 | 2364493-24-1 | Details |
| SARS-CoV-2-IN-15 | C14H9ClF3NO2 | 1580-42-3 | Details |
| SKF83959 | C18H20ClNO2 | 80751-85-5 | Details |
| MKK7-COV-9 | C18H16N4O2 | 2283355-59-7 | Details |
| MAT2A inhibitor 3 | C16H14ClN3O | 2439271-82-4 | Details |
| AChE/BChE/MAO-B-IN-1 | C20H24N2O2 | 2416910-82-0 | Details |
| GSK-1482160 | C14H14ClF3N2O2 | 1001389-72-5 | Details |
| GAT228 | C22H18N2O2 | 1446648-15-2 | Details |
| Thunbergol | C20H34O | 25269-17-4 | Details |
| Mab Aspartate Decarboxylase-IN-1 | C16H11N3O3 | 2755712-12-8 | Details |
| UNC-CA359 | C18H14ClN3O2 | 2676156-05-9 | Details |
| NLRP3-IN-11 | C17H17ClN4O2 | 2769040-91-5 | Details |
| FTO-IN-8 | C19H23ClN2O2 | 2640366-38-5 | Details |
| MFI8 | C16H18ClNO | 694488-83-0 | Details |
| Anti-inflammatory agent 15 | C17H20N2S | 474516-87-5 | Details |
| TGFβ-IN-1 | C19H18N2O | 883560-84-7 | Details |
| Cycrimine | C19H29NO | 77-39-4 | Details |
| Guanoxabenz hydrochloride | C8H9Cl3N4O | 23256-40-8 | Details |
| PI-55 | C13H13N5O | 1122579-42-3 | Details |
| BPN-15477 | C12H10ClN5 | 1971086-99-3 | Details |
| Etoxadrol | C16H23NO2 | 28189-85-7 | Details |
| Antitumor agent-68 | C17H11NO2 | 2566497-96-7 | Details |
| BTX161 | C15H16N2O3 | 2052301-24-1 | Details |
| VU0420373 | C15H11FN2O | 38376-29-3 | Details |
| Isoetharine hydrochloride | C13H22ClNO3 | 50-96-4 | Details |
| CS1 | C16H12O3 | 1448009-94-6 | Details |
| TCA1 | C16H13N3O4S2 | 864941-32-2 | Details |
| JNJ-1289 | C16H12N4OS | 792898-18-1 | Details |
| GSK2646264 | C24H26N2O2 | 1398695-47-0 | Details |
| IAA65 | C16H13F6NO2 | 2987139-96-6 | Details |
| Isofezolac | C23H18N2O2 | 50270-33-2 | Details |
| Ro 363 hydrochloride | C19H26ClNO6 | 250580-70-2 | Details |
| WIN 54954 | C18H20Cl2N2O3 | 107355-45-3 | Details |
| PI3K-IN-38 | C20H24N6O2 | 1382979-64-7 | Details |
| PBRM1-BD2-IN-3 | C14H11ClN2O | 2819989-58-5 | Details |
| Acetophenazine | C23H29N3O2S | 2751-68-0 | Details |
| BCL6-IN-6 | C27H31FN6O2S | 2408882-54-0 | Details |
| Benzonitrile, 4-[[5-cyclopropyl-3-methyl-1-[(methylsulfonyl)methyl]-1H-pyrazol-4-yl]oxy]-2,6-dimethyl- | C18H21N3O3S | 936345-34-5 | Details |
| Aldometanib | C27H43Cl2N2.I | 2904601-67-6 | Details |
| PBRM1-BD2-IN-7 | C16H15ClN2O | 2819989-68-7 | Details |
| CT52923 | C23H25N5O4S | 205256-55-9 | Details |
| DL-Willardiine | C7H9N3O4 | 19772-76-0 | Details |
| N-(4-bromo-2-chlorophenyl)-5-chloro-2-hydroxybenzamide | C13H8BrCl2NO2 | 1098360-68-9 | Details |
| Aquacycline | C22H25ClN2O9 | 423769-22-6 | Details |
| Org 25543 | C24H32N2O4 | 363628-88-0 | Details |
| VPC-18005 | C15H17N3O3S | 2242480-48-2 | Details |
| ZINC194100678 | C10H13N5O | 1995025-05-2 | Details |
| KN1022 | C21H22N6O5 | 205255-11-4 | Details |
| MT189 | C21H18FN3O2 | 1885900-35-5 | Details |
| (E)-Guanabenz | C8H8Cl2N4 | 60329-03-5 | Details |
| Product Total： Product Page： | ||||
| 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 | ||||